Kirk Chartier reports a stock award at Enova International
By AlphaYouPublished Form 4
Chartier Kirk
Reporting filer
Kirk Chartier reports a stock award, not an open-market purchase or sale, in Enova International, Inc.. Form 4 filed Nov 5, 2026 lists 1 entry.
- Disclosed
- Nov 5, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) with limited SAR (derivative) | Chartier Kirk | 2026-11-03 | A | Grant or award | 2366 | 0 | 2,366 | 2 days | Filed terms
|
Non-Qualified Stock Option (right to buy) with limited SAR (derivative)
- Owner
- Chartier Kirk
- Date
- 2026-11-03
- Code
- A
- Action
- Grant or award
- Quantity
- 2366
- Price
- 0
- Following holdings
- 2,366
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Non-Qualified Stock Option (right to buy) with limited SAR
- id: F1
- id: F2
- conversion Or Exercise Price: 186.21
- transaction Date: 2026-11-03
- transaction Form Type: 4
- transaction Code: A
- equity Swap Involved: false
- transaction Shares: 2366
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: A
- id: F3
- expiration Date: 2033-11-03
- underlying Security Title: Common stock
- 00001 per shar: par value $0.00001 per share
- underlying Security Shares: 2366
- shares Owned Following Transaction: 2366
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Chartier Kirk: Chief Strategy Officer.
- F1: The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
- F2: The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
- F3: The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: November 3, 2027, November 3, 2028 and November 3, 2029.
Original sources
Prepared automatically from public filing data. Report a correction.